False elevation of serum CA-125 level caused by human anti-mouse antibodies
- PMID: 12458896
False elevation of serum CA-125 level caused by human anti-mouse antibodies
Abstract
Discordant results were observed for serum CA-125 (carbohydrate antigen-125) assays in a patient who was monitored for recurrence of ovarian cancer. Serum CA-125 levels in this patient were normal when measured in one laboratory, but >5-times the upper limit of normal (35 U/mL) when measured in another laboratory. Both laboratories used dual antibody heterogeneous immunoassays, but from different manufacturers. Cross-linking heterophilic antibodies were suspected as a cause of the discrepancy, but the interference was not alleviated after 10-fold dilution. Assay of the patient's serum for human anti-mouse antibodies was positive, but only slightly above the reference range. Addition of blocking antibodies eliminated the interference, showing that human anti-mouse antibodies were the cause of the discrepant CA-125 results. These findings indicate that relatively low concentrations of human anti-mouse antibodies can cause significant interference in two-site immunoassays.
Similar articles
-
Transient human anti-mouse antibodies (HAMA) interference in CA 125 measurements during monitoring of ovarian cancer patients treated with murine monoclonal antibody.Gynecol Oncol. 2008 May;109(2):199-202. doi: 10.1016/j.ygyno.2008.01.025. Epub 2008 Mar 4. Gynecol Oncol. 2008. PMID: 18304620 Clinical Trial.
-
False positive carbohydrate antigen 19-9 (CA19-9) results due to a low-molecular weight interference in an apparently healthy male.Clin Chim Acta. 2009 Aug;406(1-2):41-4. doi: 10.1016/j.cca.2009.05.012. Epub 2009 May 20. Clin Chim Acta. 2009. PMID: 19463797
-
Tissue polypeptide specific antigen (TPS) and carbohydrate antigen 125 (CA-125) in the early prediction of recurrent ovarian cancer.Anticancer Res. 2002 Nov-Dec;22(6B):3669-71. Anticancer Res. 2002. PMID: 12552974
-
Heterophilic antibody interference in immunometric assays.Best Pract Res Clin Endocrinol Metab. 2013 Oct;27(5):647-61. doi: 10.1016/j.beem.2013.05.011. Epub 2013 Jun 20. Best Pract Res Clin Endocrinol Metab. 2013. PMID: 24094636 Review.
-
Analytical error and interference in immunoassay: minimizing risk.Ann Clin Biochem. 2011 Sep;48(Pt 5):418-32. doi: 10.1258/acb.2011.011073. Epub 2011 Jul 12. Ann Clin Biochem. 2011. PMID: 21750113 Review.
Cited by
-
Current approaches and challenges in managing and monitoring treatment response in ovarian cancer.J Cancer. 2014 Jan 1;5(1):25-30. doi: 10.7150/jca.7810. J Cancer. 2014. PMID: 24396495 Free PMC article. Review.
-
Inhibition of mesothelin-CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy.Lung Cancer. 2010 Jun;68(3):455-9. doi: 10.1016/j.lungcan.2009.07.016. Epub 2009 Sep 9. Lung Cancer. 2010. PMID: 19744744 Free PMC article. Clinical Trial.
-
Diminution of falsely elevated tumour markers following immunosuppression for systemic lupus erythematosus with neurological involvement.BMJ Case Rep. 2016 Apr 5;2016:bcr2016214549. doi: 10.1136/bcr-2016-214549. BMJ Case Rep. 2016. PMID: 27048397 Free PMC article.
-
Rheumatoid arthritis: correlation between rheumatoid factor levels and CA-125 tumour marker elevation.Ann Rheum Dis. 2007 Jul;66(7):980. doi: 10.1136/ard.2007.070052. Ann Rheum Dis. 2007. PMID: 17576786 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous